GR1004124B - Ασπαρτικο παραγωγο της αμλοδιπινης. - Google Patents

Ασπαρτικο παραγωγο της αμλοδιπινης.

Info

Publication number
GR1004124B
GR1004124B GR20010100602A GR2001100602A GR1004124B GR 1004124 B GR1004124 B GR 1004124B GR 20010100602 A GR20010100602 A GR 20010100602A GR 2001100602 A GR2001100602 A GR 2001100602A GR 1004124 B GR1004124 B GR 1004124B
Authority
GR
Greece
Prior art keywords
amlodipine
aspartate derivative
derivative
aspartate
hypertension
Prior art date
Application number
GR20010100602A
Other languages
English (en)
Other versions
GR20010100602A (el
Inventor
Jacobus Maria Lemmens
Theodorus Hendricus Antonius Peters
Franciscus Bernardus Gemma Benneker
Hans Jan Hoorn
Original Assignee
Pfizer Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR1004124(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Limited filed Critical Pfizer Limited
Publication of GR20010100602A publication Critical patent/GR20010100602A/el
Publication of GR1004124B publication Critical patent/GR1004124B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/90—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having more than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

να αμλοδιπινικό παράγωγο του ακόλουθου τύπου είναι χρήσιμο, είτε μόνο του ή σε συνδυασμό με αμλοδιπίνη, ως φάρμακο στην αγωγή κατά της στηθάγχης και της υπερτάσεως. ΰ
GR20010100602A 2000-12-29 2001-12-28 Ασπαρτικο παραγωγο της αμλοδιπινης. GR1004124B (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25860200P 2000-12-29 2000-12-29
US80934901A 2001-03-16 2001-03-16
PCT/NL2001/000603 WO2002053540A1 (en) 2000-12-29 2001-08-15 Aspartate derivative of amlodipine as calcium channel antagonist
BE2001/0712A BE1014455A6 (nl) 2000-12-29 2001-11-05 Aspartaatderivaat van amlodipine.

Publications (2)

Publication Number Publication Date
GR20010100602A GR20010100602A (el) 2002-10-09
GR1004124B true GR1004124B (el) 2003-01-24

Family

ID=29740328

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100602A GR1004124B (el) 2000-12-29 2001-12-28 Ασπαρτικο παραγωγο της αμλοδιπινης.

Country Status (14)

Country Link
US (1) US6479525B2 (el)
EP (1) EP1309558A1 (el)
BE (1) BE1014455A6 (el)
BR (1) BR0116553A (el)
CA (2) CA2433191A1 (el)
CR (1) CR7011A (el)
DE (1) DE20116170U1 (el)
GB (1) GB2372036B (el)
GR (1) GR1004124B (el)
HU (1) HUP0105456A3 (el)
IE (1) IES20011105A2 (el)
MX (1) MXPA03005886A (el)
WO (1) WO2002053540A1 (el)
ZA (1) ZA200110470B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285655B1 (en) * 2000-04-11 2007-05-30 Sankyo Company, Limited Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
BR0116554A (pt) * 2000-12-29 2004-02-03 Pfizer Ltd Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
MXPA03005885A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Procedimiento para fabricar maleato de amlodipina.
MXPA03005882A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
CA3038989A1 (en) 2016-10-07 2018-04-12 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
CN112334134A (zh) 2018-04-11 2021-02-05 希沃盖特制药公司 氨氯地平制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (en) 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
MXPA03005885A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Procedimiento para fabricar maleato de amlodipina.
CA2433284A1 (en) 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
GB0114709D0 (en) 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate

Also Published As

Publication number Publication date
US6479525B2 (en) 2002-11-12
CA2433191A1 (en) 2002-07-11
IES20011105A2 (en) 2002-12-30
BR0116553A (pt) 2004-02-03
GR20010100602A (el) 2002-10-09
HUP0105456A2 (en) 2002-10-28
HU0105456D0 (en) 2002-02-28
US20020128296A1 (en) 2002-09-12
CA2366391C (en) 2005-10-18
ZA200110470B (en) 2002-07-11
CA2366391A1 (en) 2002-06-29
GB2372036B (en) 2004-05-19
CR7011A (es) 2004-03-10
WO2002053540A1 (en) 2002-07-11
GB2372036A (en) 2002-08-14
BE1014455A6 (nl) 2003-10-07
HUP0105456A3 (en) 2004-01-28
GB0131064D0 (en) 2002-02-13
DE20116170U1 (de) 2002-04-04
EP1309558A1 (en) 2003-05-14
MXPA03005886A (es) 2005-04-19

Similar Documents

Publication Publication Date Title
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
NO20031672L (no) Aza- og polyazanaftalenylkarboksamid-derivater anvendbare som HIV-integraseinhibitorer
EP1268412B8 (en) Sulphonamido-substituted bridged bicycloalkyl derivatives
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
DE69907977D1 (de) Pyrrolobenzodiazepine
WO2003054146A3 (en) Self-assembly and mineralization of peptide-amphiphile nanofibers
MY138239A (en) Nitrogen containing heterobicycles as factor xa inhibitors
MXPA03008755A (es) Derivados de 2-amino-propanol.
PL361355A1 (en) Phenylglycine derivatives
AU2002223647A1 (en) Aryl-substituted indirubin derivatives, the production thereof and use of the same
AU2002228317A1 (en) Benz-1,3-azole derivatives and their uses as heparanase inhibitors
MY133969A (en) Indoloquinazolinones
GR1004124B (el) Ασπαρτικο παραγωγο της αμλοδιπινης.
AU2001264065A1 (en) Serine protease inhibitors
IL159540A0 (en) Heterocyclic compounds as selective bacterial dhfr inhibitors and the uses thereof
AU2001227122A1 (en) Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof
AU2002216649A1 (en) Benzoxazole lpaat- beta inhibitors and uses thereof
GB0030306D0 (en) Compounds
AU2002216650A1 (en) Triazine derivatives as lpaat-b inhibitors and uses thereof
CA2433193A1 (en) Amide derivative of amlodipine
MXPA03005882A (es) Derivado amida de amlodipina.
AU144678S (en) Bottle
CA2433190A1 (en) Amlodipine hemimaleate
CA96871S (en) Corner guard